<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  Physicians are advised to discuss the following issues with patients for whom they prescribe Risperidone:<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.1 Orthostatic Hypotension<BR>                     <BR>                        Patients should be advised of the risk of orthostatic hypotension, especially during the period of initial dose titration [see WARNINGS AND PRECAUTIONS (5.7)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.2 Interference with Cognitive and Motor Performance<BR>                     <BR>                        Since risperidone has the potential to impair judgment, thinking, or motor skills, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that risperidone therapy does not affect them adversely [see WARNINGS AND PRECAUTIONS (5.9)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.3 Pregnancy<BR>                     <BR>                        Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy [see USE IN SPECIFIC POPULATIONS (8.1)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.4 Nursing<BR>                     <BR>                        Patients should be advised not to breast-feed an infant if they are taking risperidone [see USE IN SPECIFIC POPULATIONS (8.3)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.5 Concomitant Medication<BR>                     <BR>                        Patients should be advised to inform their physicians if they are taking, or plan to take, any prescription or over-the-counter drugs, since there is a potential for interactions [see DRUG INTERACTIONS (7)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.6 Alcohol<BR>                     <BR>                        Patients should be advised to avoid alcohol while taking risperidone [see DRUG INTERACTIONS (7.1)].<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.7 Phenylketonurics<BR>                     <BR>                        Phenylalanine is a component of aspartame. Each 4 mg risperidone orally disintegrating tablet contains 6.72 mg phenylalanine; each 3 mg risperidone orally disintegrating tablet contains 5.04 mg phenylalanine; each 2 mg risperidone orally disintegrating tablet contains 3.36 mg phenylalanine, each 1 mg risperidone orally disintegrating tablet contains 1.68 mg phenylalanine; each 0.5 mg risperidone orally disintegrating tablet contains 0.84 mg phenylalanine and each 0.25 mg risperidone orally disintegrating tablet contains 0.42 mg phenylalanine.<BR>                        <BR>                           Rx only<BR>                        <BR>                        Manufactured by:<BR>                        <BR>                           Par Pharmaceutical Companies, Inc.<BR>                        <BR>                        Spring Valley, NY 10977<BR>                        Revised: 11/2011<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>